{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:37:27Z","timestamp":1770503847526,"version":"3.49.0"},"reference-count":47,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:p>OBJECTIVES. Prolongation of the QT interval is a risk factor for sudden death. Selective serotonin-reuptake inhibitor antidepressants can prolong the QT interval and are widely used by pregnant women. Whether antenatal exposure to selective serotonin-reuptake inhibitor causes QT prolongation in offspring is unknown. The aim of this study was to determine the effect of maternal use of selective serotonin-reuptake inhibitor antidepressants during pregnancy on the QTc interval of the offspring.<\/jats:p>\n               <jats:p>METHODS. Between January 2000 and December 2005, we collected data on all of the newborns born at a single tertiary care hospital. Electrocardiograms of infants exposed to selective serotonin-reuptake inhibitor antidepressants in utero were compared with those of healthy control newborns matched on gestational age. The tracings were interpreted by a pediatric cardiologist who was unaware of the drug exposure.<\/jats:p>\n               <jats:p>RESULTS. We identified 52 newborns exposed to selective serotonin-reuptake inhibitor antidepressants in the immediate antepartum period and 52 matched control subjects. The mean QTc was significantly longer in the group of newborns exposed to antidepressants as compared with control subjects (409 \u00b1 42 vs 392 \u00b1 29 milliseconds). Five (10%) newborns exposed to selective serotonin-reuptake inhibitor antidepressants had a markedly prolonged QTc interval (&amp;gt;460 milliseconds) compared with none of the unexposed newborns. The longest QTc interval observed among exposed newborns was 543 milliseconds. All of the drug-associated repolarization abnormalities normalized in subsequent electrocardiographic tracings.<\/jats:p>\n               <jats:p>CONCLUSIONS. Antepartum use of selective serotonin-reuptake inhibitor antidepressants is associated with QTc interval prolongation in exposed neonates. Additional research using a standardized protocol is needed to determine whether exposure to selective serotonin-reuptake inhibitor antidepressants in late pregnancy is also associated with arrhythmias.<\/jats:p>","DOI":"10.1542\/peds.2008-0658","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T13:27:57Z","timestamp":1220275677000},"page":"e710-e715","source":"Crossref","is-referenced-by-count":44,"title":["Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns"],"prefix":"10.1542","volume":"122","author":[{"given":"Gal","family":"Dubnov-Raz","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Mt Scopus, Hadassah-Hebrew University Medical Center, Jerusalem, Israel"},{"name":"BELTIS Teratology Information Center, Department of Neonatology, Rabin Medical Center, Petah Tikva, Israel; Department of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Juurlink","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pediatrics, and Health Policy, Management, and Evaluation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Fogelman","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Merlob","sequence":"additional","affiliation":[{"name":"BELTIS Teratology Information Center, Department of Neonatology, Rabin Medical Center, Petah Tikva, Israel; Department of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ito","sequence":"additional","affiliation":[{"name":"MotheRisk Program, Divisions of Clinical Pharmacology and Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[{"name":"MotheRisk Program, Divisions of Clinical Pharmacology and Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaron","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"MotheRisk Program, Divisions of Clinical Pharmacology and Toxicology"},{"name":"Pediatrics, Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Emergency Medicine, Department of Pediatrics, Hospital for Sick Children, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Clinical Pharmacology Unit, Division of Emergency Medicine, Children's Hospital, Boston, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2008,9,1]]},"reference":[{"key":"2021120905244681200_R1","unstructured":"Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: WB Saunders;1995:788\u2013811"},{"key":"2021120905244681200_R2","doi-asserted-by":"crossref","unstructured":"Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med.\u20082004;350(10):1013\u20131022","DOI":"10.1056\/NEJMra032426"},{"key":"2021120905244681200_R3","doi-asserted-by":"crossref","unstructured":"Lexchin J. Drug withdrawals from the Canadian market for safety reasons, 1963\u20132004. CMAJ.\u20082005;172(6):765\u2013767","DOI":"10.1503\/cmaj.045021"},{"key":"2021120905244681200_R4","doi-asserted-by":"crossref","unstructured":"Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health.\u20082003;12(4):373\u2013380","DOI":"10.1089\/154099903765448880"},{"key":"2021120905244681200_R5","doi-asserted-by":"crossref","unstructured":"Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol.\u20082004;103(4):698\u2013709","DOI":"10.1097\/01.AOG.0000116689.75396.5f"},{"key":"2021120905244681200_R6","doi-asserted-by":"crossref","unstructured":"Reefhuis J, Rasmussen SA, Friedman JM. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med.\u20082006;354(2):2188\u20132189","DOI":"10.1056\/NEJMc060602"},{"key":"2021120905244681200_R7","doi-asserted-by":"crossref","unstructured":"Ka\u0308lle\u0301n B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med.\u20082004;158(4):312\u2013316","DOI":"10.1001\/archpedi.158.4.312"},{"key":"2021120905244681200_R8","doi-asserted-by":"crossref","unstructured":"Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet.\u20082005;365(9458):482\u2013487","DOI":"10.1016\/S0140-6736(05)17865-9"},{"key":"2021120905244681200_R9","doi-asserted-by":"crossref","unstructured":"Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA.\u20082005;293(19):2372\u20132383","DOI":"10.1001\/jama.293.19.2372"},{"key":"2021120905244681200_R10","doi-asserted-by":"crossref","unstructured":"Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med.\u20082006;354(6):579\u2013587","DOI":"10.1056\/NEJMoa052744"},{"key":"2021120905244681200_R11","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry.\u20082006;63(8):898\u2013906","DOI":"10.1001\/archpsyc.63.8.898"},{"key":"2021120905244681200_R12","doi-asserted-by":"crossref","unstructured":"Ferreira E, Carceller AM, Agogue\u0301 C, et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics.\u20082007;119(1):52\u201359","DOI":"10.1542\/peds.2006-2133"},{"key":"2021120905244681200_R13","doi-asserted-by":"crossref","unstructured":"Thomas D, Gut B, Wendt-Nordahl G, Kiehn J. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther.\u20082002;300(2):543\u2013548","DOI":"10.1124\/jpet.300.2.543"},{"key":"2021120905244681200_R14","doi-asserted-by":"crossref","unstructured":"Witchel HJ, Pabbathi VK, Hofmann G, Paul AA, Hancox JC. Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents. FEBS Lett.\u20082002;512(1\u20133):59\u201366","DOI":"10.1016\/S0014-5793(01)03320-8"},{"key":"2021120905244681200_R15","doi-asserted-by":"crossref","unstructured":"Yap YG, Camm AJ. Drug-induced QT prolongation and torsades de pointes. Heart.\u20082003;89(11):1363\u20131372","DOI":"10.1136\/heart.89.11.1363"},{"key":"2021120905244681200_R16","doi-asserted-by":"crossref","unstructured":"Curtis LH, Ostbye T, Sendersky V, et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med.\u20082003;114(2):135\u2013141","DOI":"10.1016\/S0002-9343(02)01455-9"},{"key":"2021120905244681200_R17","doi-asserted-by":"crossref","unstructured":"Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis.\u20082003;45(5):415\u2013427","DOI":"10.1053\/pcad.2003.00101"},{"key":"2021120905244681200_R18","doi-asserted-by":"crossref","unstructured":"Varriale P. Fluoxetine (Prozac) as a cause of QT prolongation. Arch Intern Med.\u20082001;161(4):612","DOI":"10.1001\/archinte.161.4.612"},{"key":"2021120905244681200_R19","doi-asserted-by":"crossref","unstructured":"Wilting I, Smals OM, Holwerda NJ, Meyboom RH, de Bruin ML, Egberts TC. QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine. Am J Psychiatry.\u20082006;163(2):325","DOI":"10.1176\/appi.ajp.163.2.325"},{"key":"2021120905244681200_R20","doi-asserted-by":"crossref","unstructured":"Erfurth A, Loew M, Dobmeier P, Wendler G. ECG changes after paroxetine. 3 case reports. Nervenarzt.\u20081998;69(7):629\u2013631","DOI":"10.1007\/s001150050321"},{"key":"2021120905244681200_R21","unstructured":"Ravin\u0303a T, Suarez ML, Mendez-Castrillon J. Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. Int J Cardiol.\u20081998;65(3):311\u2013313"},{"key":"2021120905244681200_R22","doi-asserted-by":"crossref","unstructured":"Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol.\u20082004;42(3):277\u2013285","DOI":"10.1081\/CLT-120037428"},{"key":"2021120905244681200_R23","doi-asserted-by":"crossref","unstructured":"Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol.\u20082007;64(2):192\u2013197","DOI":"10.1111\/j.1365-2125.2007.02849.x"},{"key":"2021120905244681200_R24","doi-asserted-by":"crossref","unstructured":"Dubnov G, Fogelman R, Merlob P. Prolonged QT interval in a newborn to a fluoxetine-treated mother. Arch Dis Child.\u20082005;90(9):972\u2013973","DOI":"10.1136\/adc.2004.064618"},{"key":"2021120905244681200_R25","doi-asserted-by":"crossref","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol.\u20081997;340(2\u20133):249\u2013258","DOI":"10.1016\/S0014-2999(97)01393-9"},{"key":"2021120905244681200_R26","doi-asserted-by":"crossref","unstructured":"Chia EL, Ho TF, Rauff M, Yip WC. Cardiac time intervals of normal fetuses using noninvasive fetal electrocardiography. Prenat Diagn.\u20082005;25(7):546\u2013552","DOI":"10.1002\/pd.1184"},{"key":"2021120905244681200_R27","unstructured":"Bazett H. An analysis of the time relationship of electrocardiograms. Heart.\u20081920;7:353\u2013370"},{"key":"2021120905244681200_R28","doi-asserted-by":"crossref","unstructured":"Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med.\u20081998;338(24):1709\u20131714","DOI":"10.1056\/NEJM199806113382401"},{"key":"2021120905244681200_R29","doi-asserted-by":"crossref","unstructured":"Fridericia LS. Die Systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand.\u20081920;53:469\u2013486","DOI":"10.1111\/j.0954-6820.1920.tb18266.x"},{"key":"2021120905244681200_R30","doi-asserted-by":"crossref","unstructured":"Garson A Jr. How to measure the QT interval: what is normal?Am J Cardiol.\u20081993;72(6):14B\u201316B","DOI":"10.1016\/0002-9149(93)90034-A"},{"key":"2021120905244681200_R31","unstructured":"Garson A Jr. Electrocardiography. In: Garson A, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Baltimore, MD: Williams and Wilkins;1998"},{"key":"2021120905244681200_R32","unstructured":"Flanagan MF, Yeager SB, Weindling SN. Cardiac disease. In: MacDonald MG, Mullett MD, Seshia MM, eds. Avery's Neonatology: Pathophysiology and Management of the Newborn. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins;2005"},{"key":"2021120905244681200_R33","doi-asserted-by":"crossref","unstructured":"Schwartz PJ, Garson A Jr, Paul T, et al. Guidelines for the interpretation of the neonatal electrocardiogram. Eur Heart J.\u20082002;23(17):1329\u20131344","DOI":"10.1053\/euhj.2002.3274"},{"key":"2021120905244681200_R34","doi-asserted-by":"crossref","unstructured":"Heikkine T, Ekblad U, Laine K. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG.\u20082002;109(9):1003\u20131008","DOI":"10.1111\/j.1471-0528.2002.01467.x"},{"key":"2021120905244681200_R35","doi-asserted-by":"crossref","unstructured":"Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry.\u20082003;160(5):993\u2013996","DOI":"10.1176\/appi.ajp.160.5.993"},{"key":"2021120905244681200_R36","doi-asserted-by":"crossref","unstructured":"Loughhead AM, Fisher AD, Newport DJ, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry.\u20082006;163(1):145\u2013147","DOI":"10.1176\/appi.ajp.163.1.145"},{"key":"2021120905244681200_R37","unstructured":"Johnston MV. Conditions that mimic seizures. In: Behrman RE, Kliegman RM, Jensen HB, eds. Nelson's Textbook of Pediatrics. 17th ed. Philadelphia, PA: WB Saunders;2004;2009\u20132012"},{"key":"2021120905244681200_R38","doi-asserted-by":"crossref","unstructured":"Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J.\u20081991;122(4 pt 1):1162\u20131166","DOI":"10.1016\/0002-8703(91)90489-5"},{"key":"2021120905244681200_R39","doi-asserted-by":"crossref","unstructured":"Hussain T, Ewer AK. Maternal methadone may cause arrhythmias in neonates. Acta Paediatr.\u20082007;96(5):768\u2013769","DOI":"10.1111\/j.1651-2227.2007.00268.x"},{"key":"2021120905244681200_R40","unstructured":"Carboni MP, Garson A Jr. Ventricular arrhythmias. In: Garson A, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Baltimore, MD: Williams and Wilkins;1998"},{"key":"2021120905244681200_R41","doi-asserted-by":"crossref","unstructured":"Hosono T, Kawamata K, Chiba Y, Kandori A, Tsukada K. Prenatal diagnosis of long QT syndrome using magnetocardiography: a case report and review of the literature. Prenat Diagn.\u20082002;22(3):198\u2013200","DOI":"10.1002\/pd.283"},{"key":"2021120905244681200_R42","doi-asserted-by":"crossref","unstructured":"Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T. Expression of CYP2D6 in developing human liver. Eur J Biochem.\u20081991;202(2):583\u2013588","DOI":"10.1111\/j.1432-1033.1991.tb16411.x"},{"key":"2021120905244681200_R43","doi-asserted-by":"crossref","unstructured":"Allegaert K, Anderson BJ, Verbesselt R, et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. Br J Anaesth.\u20082005;95(2):231\u2013239","DOI":"10.1093\/bja\/aei170"},{"key":"2021120905244681200_R44","doi-asserted-by":"crossref","unstructured":"Koukouritaki SB, Manro JR, Marsh SA, et al. Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther.\u20082004;308(3):965\u2013974","DOI":"10.1124\/jpet.103.060137"},{"key":"2021120905244681200_R45","doi-asserted-by":"crossref","unstructured":"McNamara PJ, Alcorn J. Protein binding predictions in infants. AAPS Pharm Sci.\u20082002;4(1):E4","DOI":"10.1208\/ps040104"},{"key":"2021120905244681200_R46","unstructured":"Holladay JW, Dewey MJ, Yoo SD. Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha-1-acid glycoprotein levels. Drug Metab Dispos.\u20081998;26(1):20\u201324"},{"key":"2021120905244681200_R47","doi-asserted-by":"crossref","unstructured":"Loeckinger A, Kleinsasser A, Maier S, et al. Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants. Anesthesiology.\u20082003;98(3):639\u2013642","DOI":"10.1097\/00000542-200303000-00011"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/3\/e710\/1175790\/zpe0090800e710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/3\/e710\/1175790\/zpe0090800e710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T22:51:51Z","timestamp":1639090311000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/3\/e710\/72271\/Antenatal-Use-of-Selective-Serotonin-Reuptake"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,9,1]]},"published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-0658","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}